Medicare Part B: Medicare Represented At Least Half Of The Market For 22 Of The 84 Most Expensive Drugs In 2015

On December 13, 2017, the United States Government Accountability Office (GAO) released this report on Medicare's share of the market for the most expensive Medicare Part B drugs. In 2015, Medicare spent about $26 billion on Part B drugs, which are typically administered under a doctor’s supervision. The GAO looked at the 84 most expensive Part B drugs and found that for about a quarter of them, Medicare represented 50% or more of their market. By law, the amount Medicare pays for a Part B drug is generally based on the drug’s market price, no matter how . . .